Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Sleep Initiation and Maintenance Disorders 1Sarcoma 1Resectable Lung Non-Small Cell Carcinoma 1Rectal Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Multiple Myeloma 1Motor Activity 1Lymphoma, B-Cell 1Low Anterior Resection Syndrome 1Breast Cancer Lymphedema 1

Interventions

Capecitabine 29Oxaliplatin 28Fluorouracil 16Radiotherapy 15Drug Therapy 11Leucovorin 10Bevacizumab 10Surgical Procedures, Operative 9Chemoradiotherapy 8Radiation 7sintilimab 6Consolidation Chemotherapy 6tislelizumab 5spartalizumab 5Specimen Handling 5Irinotecan 5Folfox protocol 5trifluridine tipiracil drug combination 4XELOX 4Neoadjuvant Therapy 4Endoscopy 4Cetuximab 4Biopsy 4toripalimab 3pembrolizumab 3irinotecan sucrosofate 3X-Rays 3Radiotherapy, Intensity-Modulated 3Proctectomy 3Mastectomy, Segmental 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Rectal Neoplasms × Physical Therapy Modalities × Clear all
NCT06424522 2026-04-21

A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
80 enrolled
Gastrointestinal

Low Anterior Resection Syndrome, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡